These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24937691)

  • 1. Contralateral prophylactic mastectomy in the American College of Radiology Imaging Network 6667 trial: effect of breast MR imaging assessments and patient characteristics.
    Rahbar H; Hanna LG; Gatsonis C; Mahoney MC; Schnall MD; DeMartini WB; Lehman CD
    Radiology; 2014 Oct; 273(1):53-60. PubMed ID: 24937691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of contralateral prophylactic mastectomy is influenced by preoperative MRI recommendations.
    Xia C; Schroeder MC; Weigel RJ; Sugg SL; Thomas A
    Ann Surg Oncol; 2014 Dec; 21(13):4133-8. PubMed ID: 24934585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
    Pinell-White XA; Kolegraff K; Carlson GW
    Ann Plast Surg; 2014; 72(6):S153-7. PubMed ID: 24691345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing.
    Elsayegh N; Kuerer HM; Lin H; Gutierrez Barrera AM; Jackson M; Muse KI; Litton JK; Albarracin C; Afrough A; Hortobagyi GN; Arun BK
    Ann Surg Oncol; 2014 Oct; 21(11):3466-72. PubMed ID: 24796968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
    Hawley ST; Jagsi R; Morrow M; Janz NK; Hamilton A; Graff JJ; Katz SJ
    JAMA Surg; 2014 Jun; 149(6):582-9. PubMed ID: 24849045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
    Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
    Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667.
    Weinstein SP; Hanna LG; Gatsonis C; Schnall MD; Rosen MA; Lehman CD
    Radiology; 2010 Jun; 255(3):731-7. PubMed ID: 20501712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
    Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
    Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.
    King TA; Sakr R; Patil S; Gurevich I; Stempel M; Sampson M; Morrow M
    J Clin Oncol; 2011 Jun; 29(16):2158-64. PubMed ID: 21464413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of breast MRI in high-risk patients with newly diagnosed breast cancer to exclude invasive disease in the contralateral prophylactic mastectomy: Is there a role to choose wisely patients for sentinel node biopsy?
    Freitas V; Crystal P; Kulkarni SR; Ghai S; Bukhanov K; Escallon J; Scaranelo AM
    Cancer Med; 2016 Jun; 5(6):1031-6. PubMed ID: 26992816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Unilateral and Contralateral Prophylactic Mastectomy Use in Ductal Carcinoma In Situ of the Breast: Patterns and Predictors.
    Zhang B; Coopey SB; Gadd MA; Hughes KS; Chang DC; Oseni TO
    Ann Surg Oncol; 2019 Nov; 26(12):3863-3873. PubMed ID: 31325048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with the increasing trend of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ: Analysis of Surveillance, Epidemiology, and End Results data.
    You Q; Chen K; Li Y; Lai J; Fang Y; Shen S; Liu Y; Su F; Yu F
    Breast; 2018 Aug; 40():147-155. PubMed ID: 29804045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
    Tuttle TM; Jarosek S; Habermann EB; Arrington A; Abraham A; Morris TJ; Virnig BA
    J Clin Oncol; 2009 Mar; 27(9):1362-7. PubMed ID: 19224844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
    Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
    Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues of regret in women with contralateral prophylactic mastectomies.
    Montgomery LL; Tran KN; Heelan MC; Van Zee KJ; Massie MJ; Payne DK; Borgen PI
    Ann Surg Oncol; 1999 Sep; 6(6):546-52. PubMed ID: 10493622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contralateral prophylactic mastectomy: clinical and pathological features from a prospective database.
    Barry PN; Johnson RR; Harkenrider MM; Freeman AB; Kruse B; Wilson MR; Pan J; Dragun AE
    Am J Med Sci; 2012 Dec; 344(6):452-6. PubMed ID: 22395715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in Contralateral Prophylactic Mastectomy Rates According to Racial Groups in Young Women with Breast Cancer, 1998 to 2011: A Report from the National Cancer Data Base.
    Grimmer L; Liederbach E; Velasco J; Pesce C; Wang CH; Yao K
    J Am Coll Surg; 2015 Jul; 221(1):187-96. PubMed ID: 26047763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.
    Yi M; Hunt KK; Arun BK; Bedrosian I; Barrera AG; Do KA; Kuerer HM; Babiera GV; Mittendorf EA; Ready K; Litton J; Meric-Bernstam F
    Cancer Prev Res (Phila); 2010 Aug; 3(8):1026-34. PubMed ID: 20647335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
    Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
    Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.